Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
131,516,365
-
Total 13F shares
-
111,482,203
-
Share change
-
+473,241
-
Total reported value
-
$18,900,371,043
-
Put/Call ratio
-
77%
-
Price per share
-
$169.58
-
Number of holders
-
411
-
Value change
-
+$64,975,324
-
Number of buys
-
202
-
Number of sells
-
159
Institutional Holders of ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) as of Q4 2021
As of 31 Dec 2021 ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) had 411 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 111,482,203 shares of stock of the company.
Largest 10 holders included FMR LLC, VANGUARD GROUP INC, BAILLIE GIFFORD & CO, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/, Dodge & Cox, JPMORGAN CHASE & CO, STATE STREET CORP, and RTW INVESTMENTS, LP.
This table shows 415 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.